Call for Abstract

9th International conference on Tissue Science and Regenerative Medicine, will be organized around the theme “Exploring the frontiers in tissue science and Medicine”

Tissue science is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Tissue science

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Tissue engineering evolved from the field of biomaterials development and refers to the practice of combining scaffolds, cells, and biologically active molecules into functional tissues. The goal of tissue engineering is to assemble functional constructs that restore, maintain, or improve damaged tissues or whole organs.

Deregulation of normal tissue repair has dramatic consequences for life quality and survival of patients. Together, insufficient healing (chronic wounds) and excessive repair after injury (scarring/fibrosis) cause healthcare costs reaching tens of billions of dollars per year in the US alone. Chronic and fibrotic healing occurs when the body’s own repair capacity is either impaired or overwhelmed. One approach in regenerative medicine is to replace injured, diseased or aged tissues with functional tissue equivalents. This approach is challenged by adverse host reactions that are part of the body repair program, e.g., immune, inflammatory, and fibrotic responses. Thus, regenerative medicine increasingly considers to support the adult's body's own regenerative capacities to promote closure of wounds that never heal and to keep excessive repair at bay. However, it is still unclear why humans lost regenerative capacity during evolution, whereas lower organisms can regenerate whole organs.

Bone Tissue Engineering in the field of Regenerative Medicine has been the topic of substantial research over the past two decades. Technological advances have improved orthopaedic implants and surgical techniques for bone reconstruction.

Biomaterials are being used for the healthcare applications from ancient times. But subsequent evolution has made them more versatile and has increased their utility. Biomaterials have revolutionized the areas like bioengineering and tissue engineering for the development of novel strategies to combat life threatening diseases. Together with biomaterials, stem cell technology is also being used to improve the existing healthcare facilities. These concepts and technologies are being used for the treatment of different diseases like cardiac failure, fractures, deep skin injuries, etc. 

Stem cells have tremendous promise to help us understand and treat a range of diseases, injuries and other health-related conditions. Their potential is evident in the use of blood stem cells to treat diseases of the blood, a therapy that has saved the lives of thousands of children with leukaemia; and can be seen in the use of stem cells for tissue grafts to treat diseases or injury to the bone, skin and surface of the eye. Important clinical trials involving stem cells are underway for many other conditions and researchers continue to explore new avenues using stem cells in medicine.

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function.

Regenerative Approaches With Nanoparticles

Decellularization

Blastocyst Complementation

Advanced Developments In Artificial Organ System

Biobanks play a crucial role in biomedical research. The wide array of bio specimens (including blood, saliva, plasma, and purified DNA) maintained in biobanks can be described as libraries of the human organism. They are carefully characterized to determine the general and unique features of the continuous cell line and the absence or presence of contaminants, therefore establishing a fundamental understanding about the raw material from which the biological product is being derived and maintained. Biobanks catalogue specimens using genetic and other traits, such as age, gender, blood type, and ethnicity.

Human cell therapy and gene therapy is the administration of cellular and genetic material to modify or manipulate the expression of a gene product or to alter the biological properties of living cells for therapeutic use.

Gene therapy is a technique that modifies a person’s genes to treat or cure disease. Gene therapies can work by several mechanisms:

Replacing a disease-causing gene with a healthy copy of the gene

Inactivating a disease-causing gene that is not functioning properly

Introducing a new or modified gene into the body to help treat a disease

The Regenerative medicine market is expected to reach USD 38.70 Billion by 2021 from USD 13.41 Billion in 2016 at a CAGR of 23.6%.

The global market is broadly classified into types, therapy, application and regions. Based on types, the market is segmented into cell-based products and acellular products. The cell-based products is expected to dominate the global market in 2018.Based on therapy, the market is segmented into cell therapy, gene therapy, tissue engineering, and immunotherapy. Immunotherapy is the fastest growing segment in the global market, during the forecast period.

This market is also segmented by application. By application, the segments are orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications.